* Zepp Health Corp is expected to show a fall in quarterly revenue when it reports results on March 18 for the period ending December 31 2023
* The Hefei Anhui-based company is expected to report a 37.0% decrease in revenue to CNY675.703 million from CNY1.07 billion a year ago, according to the estimate from one analyst, based on LSEG data.The company's guidance on November 20 2023, for the period ended December 31, was for revenue between CNY600.00 million and CNY850.00 million.
* LSEG's mean analyst estimate for Zepp Health Corp is for earnings of 30 fen per share.
* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Zepp Health Corp is $3.99, above its last closing price of $1.17.
This summary was machine generated March 15 at 21:11 GMT. All figures in Chinese yuan renminbi unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments